Search - tctmd.com

Displaying 81 - 100 of 137

Sort: Relevancy | Date

News Industry News

STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications

July 10, 2013

News Industry News

STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial

May 20, 2013

News Industry News

World’s First Pulmonary Embolism Trial Comparing Endovascular Therapy to Standard of Care

March 08, 2013

News Industry News

STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials

March 08, 2013

News Industry News

New Abbott Test Available in Europe Provides Novel Tool to Aid Doctors in Evaluating Potential Heart Attacks

January 08, 2013

News Industry News

Case Report: Use of OrbusNeich’s Genous™ Stent with Bivalirudin for Acute Coronary Syndrome Patients at Risk for Bleeding Due to Hematological Cancer

December 16, 2012

News Industry News

Trial Finds Benefits to Using Radial Versus Femoral Access for Primary Angioplasty in Heart Attack Patients

October 26, 2012

News Industry News

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

October 26, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Industry News

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

October 24, 2012

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

News Industry News

STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing® Stent

October 22, 2012

News Industry News

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

October 18, 2012

News Industry News

Revascularization with OrbusNeich’s Genous™ Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

October 12, 2012

News Industry News

STENTYS Launches New Stent-Delivery System to Facilitate Implantation in More Complex Vessel Anatomies

September 26, 2012

News Industry News

Miracor reports First-In-Man results using its PICSO® system to treat severe heart attack patients

July 05, 2012

News Industry News

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

June 21, 2012

News Industry News

STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent

June 14, 2012

News Industry News

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

May 15, 2012

Advertisement

STENTYS Self-Apposing Stent Approved in Europe for Additional Coronary Indications

STENTYS Enrolls First Heart Attack Patient in Pivotal U.S. Clinical Trial

World’s First Pulmonary Embolism Trial Comparing Endovascular Therapy to Standard of Care

STENTYS Self-Apposing® Stent Demonstrates Lowest Mortality Rate Among Large Heart Attack Trials

New Abbott Test Available in Europe Provides Novel Tool to Aid Doctors in Evaluating Potential Heart Attacks

Case Report: Use of OrbusNeich’s Genous™ Stent with Bivalirudin for Acute Coronary Syndrome Patients at Risk for Bleeding Due to Hematological Cancer

Trial Finds Benefits to Using Radial Versus Femoral Access for Primary Angioplasty in Heart Attack Patients

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Reported at TCT 2012: InspireMD MGuard Stent Meets Primary Endpoint of MASTER Trial, Significantly Improving Prospects of Heart Attack Survival

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

STENTYS Receives FDA Approval to Initiate First U.S. Clinical Trial With Self-Apposing® Stent

Minneapolis Heart Institute Foundation Announces Schedule of Events at TCT Conference

Revascularization with OrbusNeich’s Genous™ Stent May Enable the Safe and Early Discontinuation of Dual Antiplatelet Therapy for Patients with Increased Bleeding Risk

STENTYS Launches New Stent-Delivery System to Facilitate Implantation in More Complex Vessel Anatomies

Miracor reports First-In-Man results using its PICSO® system to treat severe heart attack patients

OrbusNeich's Genous™ Stent Is Safe and Effective in Patients Who Discontinue Dual Antiplatelet Therapy (DAPT) Within 15 Days of Stent Placement

STENTYS starts clinical trial to broaden portfolio with new drug-eluting stent

Medtronic Nets New Indications for Resolute Integrity Drug-Eluting Stent in Europe

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content